UBS ETRACS 2xMonthly Leveraged S&P MLP Index ETN Series B (MLPZ) is a senior unsecured exchange-traded note issued by UBS AG that provides two times (2x) leveraged long exposure to the compounded monthly performance of the S&P MLP Index, less investor fees. The S&P MLP Index tracks the performance of master limited partnerships (MLPs) and limited liability companies (LLCs) listed on major U.S. exchanges, focusing on energy infrastructure and midstream sectors with float-adjusted market capitalization weighting, subject to concentration limits. MLPZ offers investors potential variable quarterly coupon payments linked to two times the cash distributions from the index constituents, if any, alongside monthly leverage resets designed for enhanced returns in rising MLP markets, though with amplified losses in declining conditions.
MLPZ operates within the structured products segment of the financial markets, targeting sophisticated investors seeking leveraged exposure to U.S. energy MLPs; it trades on NYSE Arca and is part of UBS's broader ETRACS suite of exchange-traded notes covering leverage, income, and commodity strategies. UBS AG, founded in 1862 and headquartered in Zurich, Switzerland, with major operations across the Americas, Europe, the Middle East, Africa, and Asia Pacific, serves as the issuer through its Investment Bank division.
In a significant development, UBS announced the mandatory redemption of all outstanding MLPZ notes on March 13, 2020, triggered by the indicative value falling below $5.00 on March 12, 2020, pursuant to the Acceleration Upon Minimum Indicative Value provision; redemption occurred via the Acceleration Amount calculated over a five-day valuation period, with settlement on March 24, 2020, effectively delisting the ETN from trading. No subsequent issuances, partnerships, acquisitions, or product relaunches related to MLPZ have been reported in recent years.